Atlas Trials

EIP Pharma Inc

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch EIP Pharma Inc

RecordFirmDate
Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia (NCT07033481)EIP Pharma Inc2025-10-02
A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke (NCT06987643)EIP Pharma Inc2025-06-20
A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies (NCT06815965)EIP Pharma Inc2024-10-16
Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies (NCT04001517)EIP Pharma Inc2019-09-30
Within Subject Crossover Study of Cognitive Effects of Neflamapimod in Early-Stage Huntington Disease (NCT03980938)EIP Pharma Inc2019-07-08
Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease (NCT03402659)EIP Pharma Inc2017-12-29

Track EIP Pharma Inc automatically

Every clearance here is in the API, with alerts when new ones post.